stella
beta
Study of LTC004 Combine With Toripalimab in Patient With Solid Tumors Resistant to Immunotherapy — Stella
Recruiting
Back to Advanced Solid Tumor trials
Phase 2 — Testing in a larger group (up to a few hundred people) to further evaluate safety and begin to assess effectiveness.
Trial locations
(1 site)
China
Cancer Institute and Hospital, Chinese Academy of Medical Sciences, Beijing
View full record on ClinicalTrials.gov